Sign inJoin waitlistJoin the waitlist

Amelia Langston

Executive Vice Chair, Department of Hematology and Medical Oncology · Emory University School of Medicine

Credentials: · · · ·

History

Department of Hematology and Medical Oncology · Emory University School of Medicine
Present
Emory University School of Medicine
Present

University of Washington Medical Center - Montlake
1988–1990
Internal Medicine
Duke University Hospital
1984–1985
Washington University School of Medicine
1980–1984
BA from Williams College
1976–1980

Research

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
New England Journal of Medicine · 2007 · 988 citations
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial
Clinical Infectious Diseases · 2007 · 552 citations
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update
Systematic review or meta-analysis · Journal of Clinical Oncology · 2018 · 478 citations

Edmund Waller
49 papers
Christopher Flowers
32 papers
HK
Hanna Khoury
31 papers
Sagar Lonial
31 papers · 2 as a fellow
LH
Leonard Heffner
22 papers
Jonathan Kaufman
20 papers
Michael Pulsipher
20 papers
Martha Arellano
19 papers · 2 as a fellow
Rainer Storb
19 papers
Brenda Sandmaier
17 papers
David Maloney
17 papers
TC
Thomas Chauncey
17 papers

Clinical trials

Allogeneic Cell Therapy for Adults With Hematologic Malignancies
Principal investigator · Completed · Phase 2
Emory University
1998–2013
Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies
Principal investigator · Completed · Phase 2
Emory University
1998–2007
Ivosidenib as Post-HSCT Maintenance for AML
Site PI · Recruiting · Phase 2
Massachusetts General Hospital
2026–2030
MAGIC Ruxolitinib for aGVHD
Site PI · Recruiting · Phase 2
John Levine
2025–2028